INTRODUCTION
The synthesis and activity of the enzymes that participate in gluconeogenesis are subjected to complex regulatory mechanisms involving tissue-specific as well as hormonal signals. The gene encoding the gluconeogenic enzyme tyrosine aminotransferase (TAT) is switched on in the parenchymal cells of the liver during the neonatal period [1] , liver-specific expression being (i) dependent on both the promoter [2, 3] and remote enhancer elements [4] and (ii) modulated by environmental cues (induced by glucocorticoids and glucagon via its intracellular mediator cAMP and repressed by insulin) at the transcriptional level [5] [6] [7] .
Both constitutive and hormone-dependent TAT regulatory sequences (promoter and enhancers) appear as modular transcriptional control units where ubiquitous (nuclear factor-Y, glucocorticoid receptor, cAMP responsive element binding protein) and liver-specific (hepatic nuclear factor 3, hepatic nuclear factor 4, nuclear factor 1 Liver , and to a smaller degree hepatic nuclear factor 1) trans-acting factors synergize [2, 3, [8] [9] [10] .
The molecular mechanisms underlying the activation of gene transcription and the interaction(s) between gene regulatory factors have been, and are currently being, thoroughly studied. In this connection, transcription in itro has proved to be a powerful tool in the experimental analysis of the tissue-specific Abbreviations used : AdML, adenovirus major late promoter ; CNEs, crude nuclear extracts ; ds-oligo, double-stranded oligonucleotide ; EMSA, electrophoretic mobility-shift assay ; ERE, oestrogen response element ; GR, glucocorticoid receptor ; GRE, glucocorticoid response element ; hGRα, recombinant human glucocorticoid receptor ; HPIEC, high-performance ion-exchange chromatography ; PRE, progesterone response element ; Sf9-NEs, nuclear extracts prepared from Sf9 insect cells ; TA, triamcinolone acetonide ; TAT, tyrosine aminotransferase ; TAT 0. 35 , 5h flanking sequences of the TAT gene spanning nt k350 to j1 (TAT promoter).
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scription in itro (1.5-4.5-fold) was dependent on the amount of added hGRα and independent of the nature (agonist or antagonist) of the ligand. Moreover, the hGRα-mediated stimulation of transcription was (i) dependent on GRE\progesterone response element (PRE) (it was inhibited by a 25-fold excess of GRE\PRE but not by a 100-fold excess of oestrogen response element) and (ii) receptor-dependent (Sf9-NEs prepared from uninfected Sf9 cells or from Sf9 cells infected with wild-type baculoviral DNA did not enhance transcription). Taken together, these experiments support the conclusions that in itro the glucocorticoid receptor is able to enhance transcription from genomic, liver-specific, promoter sequences (those of the TAT gene), and that this enhancement of transcription from the liverspecific TAT !.$& promoter is dependent both on the glucocorticoid receptor and on the latter's interaction with its cognate response elements.
activity of genomic promoter sequences (e.g. albumin, pyruvate kinase and TAT), each consisting of a modular transcriptional unit composed of a unique array of cis elements for both ubiquitous and tissue-specific trans-acting factors [2, 3, 11, 12] . In contrast, artificial constructs encompassing only minimal promoter and enhancer elements [e.g. a TATA box 5h-flanked with either two glucocorticoid response elements (GRE\PRE, where PRE stands for progesterone response element) or the vitellogenin A2 oestrogen response element (ERE)] have allowed the demonstration that steroid hormone receptors can form functional pre-initiation complexes with RNA polymerase II and other transcription activating factors associated with the basal transcriptional machinery [13] [14] [15] [16] [17] [18] [19] .
Only a few studies on transcription in itro have made use of hormone-inducible genomic promoter sequences as DNA templates for the study of steroid hormone receptor-dependent transcription [20] [21] [22] , and in no case were such promoters able to drive tissue-specific transcription. Even the Xenopus lae is vitellogenin B1 promoter, which is exclusively transcribed in the liver of female X. lae is toads in i o, is unable to drive liver-specific transcription in itro on its own. It is as active in the presence of crude nuclear extracts prepared from an established cell line of X. lae is kidney (B3.2) and from human HeLa cells as in the presence of those prepared from female X. lae is livers [23] , implying that additional mechanisms are instrumental in the repression of gene expression in non-hepatic cells.
We have previously shown that the TAT promoter (TAT !.$& , spanning nt k350 to j1) is able to drive liver-specific transcription in itro [2, 3] . Here we report that a single GRE\PRE (the TAT GREII), even when located at a remote 5h-position (k350 bp relative to the transcription's initiation site), is able to enhance transcription from TAT !.$& in the presence of rat liver crude nuclear extracts, provided that these nuclear extracts were supplemented with partly purified recombinant human glucocorticoid receptor (hGRα).
MATERIALS AND METHODS

Plasmids and recombinant baculovirus
pAdML $(& (where AdML refers to adenovirus major late promoter), pAdML #(! , pTAT $(& and pRShGRα have been described previously by Sawadogo and Roeder [24] , Vaulont et al. [12] , Schweizer-Groyer et al. [2, 3] and Hollenberg et al. [25] respectively.
Construction of pGRE-TAT 148
A 173 bp fragment encompassing a 148 bp ' G-free ' cassette was amplified by PCR with p(C # AT) "* [24] as a template and the following primers : 5h, 5h-AATTCGAGCTCATATATTC-TCCTTCCATACCCCCTATCATCC-3h ; 3h, 5h-CTCTAGA-GGATCCCCGGGAGTGGAATGAGAAATGAGTG-3h. The fragment was then gel-purified and restricted by SstI and BamHI (underlined restriction sites in the 5h and 3h primers respectively).
A chimaeric TAT-GREII\TAT-promoter fragment (GRE-TAT !.$& ) was also engineered by PCR amplification with pTC10 [9] as a template, and the following primers : forward, 5h-TCAAGAATTCAGGTTTACCAATCTCTGCTGTACAGGAT GTTCTAGCGGTACCAGAAGGACCCTCGTTTAAATGTA-TTT-3h ;reverse,5h-TGATGAGCTCAGGTGCAGTCCTGA-3h. This 400 bp fragment encompassed 36 bp of the TAT GREII (nt k2523 to k2488 ; bold characters in the forward primer) linked to the 350 bp KpnI-SstI fragment of the TAT promoter (nt k350 to j1) immediately 5h of the KpnI site (italics in the forward primer). After amplification this fragment was gelpurified, then restricted with EcoRI and SstI (underlined restriction sites in the 5h and 3h primers respectively).
Both restricted PCR fragments were mixed together and with EcoRI and BamHI-digested pT ( T $ 18U. Ligation of these fragments yielded pGRE-TAT "%) (see Figure 1A ). Its sequence was confirmed by dideoxy sequencing.
Construction of baculovirus-hGRα recombinant viruses (BachGRα)
hGRα cDNA sequences (insert) were excised from pRShGRα as a 3 kb KpnI-XhoI fragment, and vector DNA (pBlueBac ; Invitrogen) [26] was linearized by restriction at the unique NheI site. After filling-in with Klenow DNA polymerase, blunt-ended vector and insert DNA species were ligated. The recombinant pBlueBac plasmids were co-transfected into Spodoptora frugiperda (Sf9) cells together with wild-type viral DNA by using the calcium phosphate co-precipitation procedure [27] . The plaques that corresponded to BachGRα were selected [they became blue in the presence of the β-galactosidase indicator Bluo-Gal (150 µg\ml)] and then purified by three rounds of plaque purification.
The hGRα protein synthesized in BachGRα-infected cells was of the expected molecular mass and was able to bind glucocorticoid agonists and antagonists.
Cell culture, transfection and infection
COS-7 cells were maintained in exponential-phase monolayer culture in Dulbecco's modified Eagle's medium supplemented with 10 % (v\v) foetal calf serum\50 µg\ml gentamicin\2 mM -glutamine. Transfection was performed by the DEAE-dextran procedure as previously described [28] .
Sf9 cells were grown as spinner cultures in TNM-FH medium (Sigma) supplemented with 10 % (v\v) steroid-depleted foetal calf serum (10-TNM) [29] . Sf9 cells were routinely infected with BachGRα recombinant virus at a multiplicity of more than 10. Briefly, 6 ml of 10-TNM containing approx. 6i10( cells was mixed with 3 ml of recombinant virus suspension ; 2 h after infection, the cells were diluted with 60 ml of fresh 10-TNM and grown as spinner cultures for an additional 46 hours. 
Isolation of hGRα for transcription in vitro
pRShGRα-transfected COS-7 cells were harvested 48 h after transfection, washed and homogenized as previously described [28] . The homogenate was centrifuged at 105 000 g for 60 min (0-4 mC), and the high-speed supernatant was fractionated by high-performance ion-exchange chromatography (HPIEC) with a Mono Q column [30] . The hGRα-containing fraction (0.32 M NaCl eluate ; 0.5 pmol hGRα\ml) was concentrated and desalted with Centricon 30 microconcentrators. The 0.32 M NaCl eluate obtained by Mono Q fractionation of high-speed supernatants prepared from untransfected COS-7 cells yielded preparations of mock-purified hGRα.
BachGRα-infected Sf9 cells (6i10( cells) were harvested by centrifugation and washed with 5 ml of chilled PBS ; the nuclear extracts were prepared by the method of Elliston et al. [31] , with minor modifications. All subsequent steps were performed at 0-4 mC. The washed cell pellet was resuspended and lysed in 4 ml of hypotonic buffer [HMKD ; 10 mM Hepes (pH 7.9)\15 mM MgCl # \10 mM KCl\2 mM dithiothreitol) and centrifuged at 3000 g for 10 min. Except when cytosol was to be prepared, the supernatant was discarded and the pellet was centrifuged for an additional 10 min at 27 000 g. The small volume of remaining supernatant was discarded, and the final nuclear pellet was resuspended 1 : 1 (v\v) in 20 mM Hepes (pH 7.9)\20 % (v\v) glycerol\0.55 M KCl\1.5 mM MgCl # \0.2 mM EDTA\2 mM dithiothreitol\2 µg\ml leupeptin\2 µg\ml antipain\1 % (w\v) aprotinin\20 µg\ml PMSF (nuclear extract buffer). The efficiency of nuclear lysis was improved by using a Dounce homogenizer (B pestle, 10 strokes), and the lysate was centrifuged at 12 000 g for 30 min. The final supernatant was divided into aliquots (referred to hereafter as Sf9-NEs) and stored for several months in liquid nitrogen. In each Sf9-NE, hGRα was assayed by the hydroxyapatite method [32] . Its specific activity (as expressed in pmol\mg of protein) varied slightly from one preparation to the other.
Sf9-NEs were also prepared from uninfected Sf9 cells (6i10( cells) and from Sf9 cells that had been infected with wild-type baculoviral DNA, and were used as control Sf9-NEs (i.e. devoid of hGRα).
When required, the high-speed supernatant (cytosol) was prepared, centrifuging the post-nuclear (3000 g, 10 min) supernatant at 105 000 g for 60 min.
Transcription assay in vitro
Crude liver nuclear extracts (liver CNEs) were prepared by the method of Gorski et al. (11) . The transcription assay in itro was performed as described in Schweizer-Groyer et al. [2, 3] . The sequence of addition of reagents is shown in Figure 1 (B). Each transcription assay contained two DNA templates : pTAT $(& or pGRE-TAT "%) (400 ng), from which transcription was driven by TAT promoter (TAT !.$& ) or chimaeric TAT promoter\enhancer sequences (GRE-TAT !.$& ), and pAdML #(! or pAdML $(& (100 ng), internal controls from which transcription was driven by AdML ( Figure 1A ). Correct initiation of transcription from these templates gave rise to transcripts of 375, 148, 280 and 385 nt respectively.
Electrophoretic mobility shift assay (EMSA)
Double-stranded poly(dI):poly(dC) (1µg) was mixed with 10 µg of crude liver nuclear extracts in the presence or absence of recombinant hGRα (0.4 pmol, Sf9-NEs prepared from Sf9 cells that had been infected with BachGRα) and incubated at 0 mC for 15 min. $$P-Labelled GRE\PRE (perfect palindrome ; see below) (1 ng ; approx. 30 000 c.p.m.) was then added either alone or in the presence of a 25-100-fold molar excess of unlabelled doublestranded oligonucleotide (ds-oligo) (GRE\PRE or ERE ; see below). The final reaction mixture [20 µl ; 20 mM Hepes (pH 7.4)\4 mM dithiothreitol\37.5 mM KCl\2.5 mM NaCl\1 mM EDTA\75 µM MgCl # \0.5 % BSA\10 % (v\v) glycerol] was incubated for an additional 60 min at 25 mC, then analysed by non-denaturing PAGE [5 % (w\v) gel] run in 0.25iTris\ borate\EDTA buffer at 0-4 mC. Gels were dried and DNAprotein interactions were detected by autoradiography (24-48 h at room temperature).
When supershift experiments were to be performed, the 60 min incubation at 25 mC was extended for an additional 20 min after the addition of anti-GR polyclonal antibody in the reaction mixture (1 µl) [33] .
Western blot analysis
Western blotting was performed as previously described [28] . The rabbit anti-hGR polyclonal antibody was raised against a synthetic peptide (amino acid residues 149-168 of the hGR), and was able to interact with both native and SDS-treated hGR. Depending on the experiment, diaminobenzidine (Vectastain ABC) or chemiluminescent (ECL System ; Amersham) peroxidase staining were used.
Oligonucleotides
Two ds-oligos were used as competitors, both in the transcription experiments in itro and in EMSA : the ERE from the Xenopus lae is vitellogenin gene [34] , 5h-GTCCAAAGTCAGGTCA CAGTGACCTGATCAAAGTT-3h, and a perfectly palindromic GRE\PRE, 5h-GATCATCTCTGCAGAACAGGATGTTCT-AGCTACTTGATC-3h.
Quantitative analyses
Authentic transcripts generated from the AdML, TAT !.$& and GRE-TAT !.$& promoters were quantified by densitometric scanning of the autoradiograms (Bio-Image System ; Millipore). For each experiment, multiple exposures (in the range 8-48 h) were scanned. The amount of transcripts generated from TAT !.$& and from GRE-TAT !.$& promoters was always standardized relative to that generated from AdML, and this ratio (TAT\AdML relative transcription) was used to compute the glucocorticoid receptor (GR)-mediated enhancement of transcription : Stimulation relative to control (TAT\AdML relative transcription measured in the presence of hGRα) divided by (TAT\AdML relative transcription measured in the absence of hGRα).
RESULTS
The glucocorticoid-responsive template (pGRE-TAT "%) ) used in the transcription experiments in itro ( Figure 1A ) contained the rat TAT gene GREII sequences lying between nt k2523 and k2488 (i.e. including the CCAAT motif located between nt k2523 and k2506) [8] . This motif was included because transient transfection experiments reported by Stra$ hle et al. [35] have shown (i) that the 15 bp GRE\PRE itself is unable to mediate hormone inducibility when inserted 351 bp upstream of the TAT gene's cap site, and (ii) that the GR acts synergistically with the trans-acting factor (probably C\EBP) [9] that interacts with this CCAAT motif.
Figure 1 Transcription vectors and design of the transcription reaction in vitro
(A) ' Open weave ' boxes represent full-length (375 bp : pAdML 375 , pTAT 375 ) or shortened (148 bp : pGRE-TAT 148 ; 270 bp : pAdML 270 ) ' G-free ' cassettes. AdML 5h flanking sequences (nt k340 to j1) and nt j1 to j10 of the AdML transcript are depicted as hatched and filled boxes respectively. Open and chequered boxes represent promoter (nt k350 to j1) and GREII (nt k2523 to k2488) sequences from the TAT gene respectively. (B) Test (pGRE-TAT 148 or pTAT 375 ; 400 ng) and 100 ng of control (pAdML 375 or pAdML 270 ) DNA templates, the transcription reaction mixture (without rNTPs), 48 µg of liver CNEs and hGRα that had previously been preincubated at 0 mC for 15 min in the presence of 0.5 µg of salmon sperm DNA were sequentially mixed as shown. After an additional 10 min of incubation at 0 mC, the transcription reaction was started, adding the rNTPs, and transcription was performed at 30 mC for 45 min.
Figure 2 Liver CNEs do not interact with a GRE/PRE unless they are supplemented with hGRα-containing Sf9-NEs
EMSA (see the Materials and methods section) was performed in the presence of liver CNEs (10 µg of protein) and in the presence (lanes 2-6) or absence (lane 1) of 0.4 pmol of hGRα (Sf9-NEs prepared from Sf9 cells that had been infected with BachGRα). To identify authentic GR-GRE/PRE complexes, incubations were also performed in the presence of unlabelled ERE (100-fold molar excess, lane 5) or GRE/PRE (25-fold or 100-fold molar excesses, lanes 3 and 4), or in the presence of anti-GR polyclonal antibody (aGRab ; lane 6). Abbreviations : [GR] 2 , retarded band corresponding to GR homodimers ; S GR , super-shifted hGRα-GRE complexes ; Ori, upper limit of the gel. 
Rat liver CNEs are devoid of GR
Because TAT !.$& behaves as a liver-specific promoter [2, 3] , a prerequisite for efficient transcription from pGRE-TAT "%) was the use of liver CNEs. However, preliminary experiments have shown that rat liver CNEs were unable to support glucocorticoiddependent transcription in itro (results not shown). One possible explanation for such results would be that rat liver CNEs were devoid of GR. We addressed this issue with the highly sensitive electrophoretic mobility-shift asssay, with a perfectly palindromic GRE (i.e. the one that displays the highest affinity for the GR) [33] .
As a matter of fact, only gel-shift experiments performed in the presence of liver CNEs supplemented with exogenous hGRα (i.e. Sf9-CNEs prepared from Sf9 cells infected with BachGRα) yielded GR-GRE\PRE complexes (Figure 2, compare lanes 1  and 2) . That the retarded band ([GR] # ) represented genuine GR-GRE\PRE complexes was ascertained both by competition experiments (it was extinguished by 25-and 100-fold molar excesses of unlabelled GRE\PRE but not by a 100-fold molar excess of ERE) (Figure 2 , lanes 3-5) and by immunological recognition of hGRα (hGRα-GRE\PRE complexes were supershifted when anti-GR polyclonal antibodies were added to the reaction mixture) (Figure 2 , lane 6).
The hGRα used in the transcription experiments in vitro : origin and molecular form
Two sources of hGRα (i.e. isolated from Sf9 cells infected with BachGRα or from COS-7 cells transiently transfected with pRShGRα) were routinely used in the transcription experiments in itro. When BachGRα-infected Sf9 cells were cultured in 10-TNM in the absence of (anti)-hormone, no immunoreactivity against GR could be detected by Western blot analysis of the crude nuclear extracts (Figure 3, lane 1, ' hGRα-depleted ' Sf9-NEs). Accordingly, immunoreactivity against GR was recovered at 90 kDa in the low-speed (800 g, 10 min ; Figure 3 , lane 5) and in the highspeed (cytosol ; Figure 3 , lane 4) supernatants prepared from the homogenate of these cells.
In contrast, when such an analysis was performed with BachGRα-infected Sf9 cells that had previously been cultured in 10-TNM in the presence of 1 µM steroid (TA or RU486), a strong immunoreactivity was observed in the Sf9-NEs (Figure 3 , lanes 2 and 3), but was undetectable in the low-speed supernatant ( Figure 3, lane 6 ). When such Sf9-NEs were analysed by glycerol gradient ultracentrifugation, hGRα sedimented as the transformed 3-4 S form (results not shown).
Similarly, after HPIEC fractionation of high-speed supernatants prepared from pRShGRα-transfected COS-7 cells, the partly purified hGRα was recovered as the 3-4 S transformed form (results not shown), consistent with the use of high salt conditions during the ion-exchange (Mono Q) procedure [30] .
hGRα enhances transcription in vitro from pGRE-TAT 148
The final design of the transcription reaction outlined in Figure  1 (B) resulted from preliminary experiments showing that transcription in itro was inhibited when the hGRα preparations obtained either from COS-7 cells or from Sf9 cells had not been preincubated with non-specific salmon sperm DNA before addition to the transcription mixture (G. Schweizer-Groyer, unpublished work). Moreover because the preincubation of template DNA species with CNEs is essential for the generation of ' rapid-start ' preinitiation complexes, the formation of which is enhanced by progesterone, glucocorticoid and oestrogen receptors [13, 14, 18] , a 10 min lag was applied before initiation of the transcription reaction (addition of rNTPs in the reaction mixture) ( Figure 1B) . In most cases the basal level of transcription (i.e. constitutive transcription from the GRE-TAT !.$& promoter\enhancer elements) measured in the absence of hGRα-containing extracts was high when liver CNEs were used as a source of general transacting factors ( Figure 4A , lane 1 ; Figure 4B , # ; Figure 5A , lanes 1, 2, 4 and 6 ; Figure 6 , lane 1). This phenomenon could be explained by the fact that liver CNEs contain both the liverspecific and ubiquitous trans-acting factors that are required for optimal transcription from TAT !.$& promoter sequences [2, 3] . When increasing amounts of Sf9-NEs containing TA-hGRα complexes (range 20-750 fmol of hGRα) were added to the transcription mixture, the variation in TAT\AdML relative transcription was biphasic : it increased in a dose-dependent
Figure 4 hGRα expressed in Sf9 and in COS-7 cells enhances transcription in vitro from GRE-TAT 0.35
(A) Aliquots of Sf9-NEs prepared from uninfected Sf9 cells (1.8 µl ; lane l) or from BachGRα-infected Sf9 cells (0.23-4.7 µl ; lanes 2-6) were added to the transcription mixture ; the reaction proceeded as outlined in Figure 1(B) . The molar ratios of hGRα to pGRE-TAT 148 ranged from 0.5 to 10 and are indicated above each lane (GR/template). AdML and GRE-TAT (at the right) indicate correctly initiated control and test transcripts respectively. The increase in transcription mediated by the addition of hGRα in the transcription reaction (stimulation relative to control) was computed as outlined in the Materials and methods section, and is indicated below each lane. (B) In each reaction mixture the amounts of transcript generated from GRE-TAT 0.35 were standardized relative to those generated from AdML, and the corresponding ratio (TAT/AdML relative transcription) was plotted as a function of hGRα input (lower abscissa) or of GR/template (upper abscissa). (C) Aliquots (4.5-13.5 µl) of pooled, hGRα-containing HPIEC fractions were added to the transcription mixture (GR/template ; range 1-3) ; the reaction proceeded as outlined in Figure 1(B) . In each reaction mixture the amounts of transcript generated from GRE-TAT 0.35 were standardized relative to those generated from AdML, and the corresponding ratio (TAT/AdML relative transcription) was plotted as a function of hGRα input (lower abscissa) or of GR/template (upper abscissa).
manner at GR-to-template ratios below 3.75 (between 30 and 250 fmol of added hGRα), was maximal up to a GR-to-template ratio of 5 (between 250 and 350 fmol of added hGRα), then decreased when this ratio was larger (more than 350 fmol of added hGRα). At optimal GR-to-template ratios (3.75-5.00), transcription from the GRE-TAT !.$& promoter was stimulated 3.2-3.5-fold relative to that obtained in the absence of added receptor ( Figures 4A, lanes 2-6, and 4B) .
That the presence of hGRα in the Sf9-NEs was indispensable in enhancing transcription from GRE-TAT !.$& was supported by the results shown in Figure 5 (A). Transcription was not enhanced (i) when Sf9-NEs were prepared from Sf9 cells that had been infected with wild-type baculoviral DNA (i.e. it does not drive hGRα expression in Sf9 cells) ( Figure 5A , lane 2) and (ii) when Sf9-NEs (1.0 or 1.6 µg of protein) that do not contain TA-hGRα complexes (i.e. prepared either from uninfected Sf9 cells, or from BachGRα-infected Sf9 cells that had not been preincubated with the agonist before homogenization ; see Figure 3 ) were added to the transcription mixture in itro ( Figure 5A, lanes 1 and 6-8) .
A dose-dependent stimulation of transcription (maximum 3-fold) was also obtained when partly purified TA-hGRα complexes (i.e. HPIEC fractions isolated from COS-7 cells transiently transfected with pRShGRα) were added to the transcription mixture ( Figure 4C ). With this source of receptor, the GR-totemplate ratio for maximal enhancement of transcription was 2.5 (180 fmol of added hGRα). In contrast, transcription was not Replicate aliquots of Sf9-NEs (1.1 µg of protein and/or GR/template l 2.5) were added to the transcription mixture ; the reaction proceeded as outlined in Figure  1(B) . In this series of experiments, liver CNEs were replaced by HeLa cell nuclear extracts as a source of general transcription factors. For both panels, TAT/AdML relative transcription was calculated under each experimental condition compared with the appropriate control (Sf9-NEs from uninfected Sf9 cells or mock purified GR) and is expressed as fold stimulation relative to that control as outlined in the Materials and methods section for glucocorticoid-enhanced transcription.
Figure 5 Stimulation of transcription by Sf9-NEs prepared from BachGRα-infected Sf9 cells or from hGRα-containing HPIEC fractions is dependent on both the hGRα and liver nuclear proteins
enhanced when partly purified TA-hGRα complexes were replaced by mock-purified hGRα (i.e. HPIEC fractions isolated from untransfected COS-7 cells) ( Figure 5A , compare lanes 4 and 5).
Finally, when nuclear extracts of HeLa cells were used instead of liver CNEs as a source of general trans-acting factors, transcription from GRE-TAT !.$& was identical in the presence (hGRα-containing Sf9-NEs) and in the absence (hGRα-depleted Sf9-NEs) of hGRα in the reaction mixture ( Figure 5B , compare lane 11 with lanes 9 and 10). These results support the conclusion that the presence of liver-specific trans-acting factor(s) is a prerequisite for hGRα to enhance transcription from GRE-TAT !.$& .
Enhancement of transcription by hGRα is dependent on GR-GRE/PRE interaction
We next addressed the point of whether or not hGRα-mediated stimulation of transcription was dependent on hGRα-GRE\PRE interaction.
In the experiment shown in Figure 6 , transcription from GRE-TAT !.$& was enhanced 4.5-fold on the addition of TA-hGRα
Figure 6 Stimulation of transcription by Sf9-NEs prepared from BachGRα-infected Sf9 cells is dependent on GREs
(A) Sf9-NEs were prepared from wild-type baculoviral DNA-infected (Bac, lane 5) or from BachGRα-infected (BacGR, lanes 2-4, 6) Sf9 cells after a 1 h incubation of the cells in the presence of 1 µM TA. Replicate aliquots of Sf9-NEs (lanes 2-4, 1.6 µg of protein, GR/template l 3.75 ; lanes 5 and 6, 1.1 µg of protein, GR/template l 2.5) or an identical volume of nuclear extract buffer (lane 1) were added to the transcription mixture ; the reaction proceeded as outlined in Figure 1 (B). When indicated above the lane, a ds-oligo encompassing authentic ERE (100-fold molar excess) or GRE/PRE (25-fold molar excess) was added to the reaction mixture together with the DNA template. AdML and TAT or GRE-TAT (at the right of each panel) indicate correctly initiated control and test transcripts respectively. TAT/AdML relative transcription was calculated under each experimental condition compared with the appropriate control (nuclear extract buffer or Sf9-NEs prepared from Sf9 cells infected with wild-type baculoviral DNA) and is expressed as stimulation relative to that control as outlined in the Materials and methods section for glucocorticoidenhanced transcription.
complexes (270 fmol ; 1.6 µg of Sf9 nuclear proteins) to the transcription mixture in itro. The magnitude of hGRα-mediated enhancement of transcription was decreased to 2.5-fold in the presence of competing GRE\PRE in the reaction mixture (25-fold molar excess) but remained unchanged (4.3-fold) in the presence of a 100-fold molar excess of ERE ( Figure 6, lanes 1-4) . Moreover, when GRE-TAT !.$& was replaced by TAT !.$& (which does not contain GREII sequences upstream of the TAT gene's promoter sequences), transcription was identical whether Sf9-NEs had been prepared from Sf9 cells infected with wild-type baculoviral DNA or from Sf9 cells infected with BachGRα ( Figure 6 , compare lanes 5 and 6).
Taken together, these results support the conclusions that the stimulation of transcription obtained in the presence of nuclear extracts prepared from BachGRα-infected Sf9 cells was dependent both on the GR and on its interaction with its cognate response elements (i.e. the GREII sequences flanking the TAT !.$& promoter element in pGRE-TAT "%) ).
Antagonist (RU486)-hGR complexes stimulate transcription in vitro
Incubation of BachGRα-infected Sf9 cells with 1 µM RU486 yielded RU486-hGRα complexes in the nuclear extracts (see Figure 3 , lane 3). Such nuclear extracts were able to enhance transcription in itro from GRE-TAT !.$& (2.1-fold stimulation relative to control) ( Figure 7, lanes 1 and 2) . RU486-hGRα-enhanced transcription was completely abolished in the presence of a 25-fold molar excess of GRE\PRE in the transcription mixture, but remained unchanged (2.8-fold stimulation) in the presence of ERE (100-fold molar excess) (Figure 7, lanes 3  and 4) .
These results support the conclusions (i) that the transformed RU486-hGRα complexes present in the Sf9-NEs are able to stimulate transcription in itro from a GRE\PRE-containing template and (ii) that this enhancement is dependent on [RU486-hGRα]-GRE\PRE interactions.
Figure 7 hGRα-RU486 complexes stimulate transcription in vitro
Sf9-NEs were prepared from uninfected (lane 1) or BachGRα-infected (lanes 2-4) Sf9 cells after a 1 h incubation of the cells in the presence of 1 µM RU486. Replicate aliquots (0.8 µg of protein, GR/template l 3.75) of the nuclear extracts were added to the transcription mixture ; the reaction proceeded as outlined in Figure 1 (B). When indicated above the lanes, a ds-oligo encompassing an authentic ERE (100-fold molar excess) or GRE/PRE (25-fold molar excess) was added to the reaction mixture together with the DNA template. AdML and GRE-TAT (at the right) indicate correctly initiated control and test transcripts respectively. The stimulation of transcription relative to control was computed as outlined in the Materials and methods section and is indicated below each lane.
DISCUSSION
Previous results obtained in our laboratories have demonstrated that the TAT promoter (TAT !.$& ) is able to drive liver-specific transcription in itro [2, 3] . We now report that the GR is able to enhance transcription in itro from TAT !.$& , provided that (i) a GRE\PRE is inserted 5h to the promoter sequences in the reporter construct and (ii) the rat liver CNEs are supplemented with recombinant glucocorticoid-receptor. When transcription in itro was performed in the presence of rat liver CNEs alone, the transcriptional activity of GRE-TAT !.$& was identical irrespective of the presence or absence of dexamethasone in the transcription mixture. This is in contrast with what has previously been reported for oestrogen-dependent transcription with Xenopus lae is liver CNEs [20] , and could be due either to the constitutive activity of already transformed GR molecules that are present in the crude liver nuclear extracts or to the lack of GR in such liver CNEs. Highly sensitive EMSA analysis of rat liver CNEs supported the latter hypothesis.
That liver CNEs were devoid of GR might be explained either by its cytoplasmic localization in the absence of hormone or by the leakage of unliganded receptor molecules out of the nuclei during the homogenization procedure under hypoionic conditions (the rats did not receive any glucocorticoid injection before being killed). Indeed, numerous immunocytochemical studies have shown that the unliganded GR, in contrast with the oestrogen and progesterone receptors, was either cytoplasmic or could easily leak out of the cell's nucleus [36, 37] . Such explanations also hold true for the absence of immunoreactive hGRα in Sf9-NEs prepared from Sf9 cells infected with BachGRα and homogenized without prior incubation with TA or RU486, and for its correlated presence in low-and high-speed supernatants.
When the liver CNEs were supplemented with exogenous hGRα, the transcriptional activity driven by the chimaeric GRE-TAT !.$& promoter-enhancer construct was enhanced over that observed in the absence of hGRα. That this enhancement was due to the exogenous hGRα could be inferred from four observations : (i) it was not observed in the presence of Sf9-NEs prepared either from uninfected Sf9 cells, from Sf9 cells infected with wild-type baculoviral DNA or from BachGRα-infected cells that had not previously been incubated with TA or RU486 (see above), (ii) its magnitude was dependent on the amount of receptor added, (iii) it was diminished to approx. one-half in the presence of a 25-fold molar excess of competing TAT-GREII dsoligo (but not of competing ERE at a 100-fold molar excess) in the reaction mixture, and (iv) it was not obtained when TAT-GREII sequences were omitted from the DNA template (pTAT $(& ). The decrease in transcriptional stimulation observed at the highest GR-to-template ratio (of 10) might be due to selfsquelching, a phenomenon that has already been reported to occur in itro in the presence of the [A\B]-transcriptional activation function (TAF-1) of the human progesterone receptor [38] .
Finally it should be emphasized that the use of GRE-TAT !.$& as a chimaeric promoter\enhancer element yielded a highly liverspecific enhancement of transcription in itro by hGRα.
The maximal increase in transcription (i) was in the same range whether recombinant hGRα was obtained by using insect (Sf9 ; 3.2-3.5-fold) or mammalian (COS-7 ; 2.5-fold) cells and (ii) was achieved at similar GR-to-template ratios (3.75 and 2.5 in the presence of hGRα synthesized in Sf9 and COS-7 cells respectively). These observations support the conclusion that the hGRα protein that is produced in insect and mammalian cells is equally active, and suggest that the two cell systems do not differ in post-translational protein modification, at least with regard to the transcriptional efficiency of hGRα.
When a chimaeric DNA template that encompasses a single GRE\PRE located approx. 20 bp upstream of minimal promoter elements (TATA box) was incubated with nuclear extracts of HeLa cells and purified chicken progesterone receptor (cPRa), a maximal enhancement of approx. 5-fold was obtained in transcription experiments in itro [13] . Receptor-mediated increase in transcription in itro was much more efficient (10-30-fold) when the DNA templates contained either multiple close GRE\PREs (mouse mammary tumour virus -long terminal repeat) or tandem GRE\PREs (or EREs) inserted approx. 20 bp upstream of minimal promoter elements (TATA box) [13, 14] . This high level of transcriptional enhancement is due to synergistic induction of transcription [13] , a consequence of co-operative binding of progesterone or GRs to adjacent GRE\PREs [39, 40] . Moreover, this functional synergism between tandem GRE\PREs is attenuated when the hormone response elements are inserted in a remote 5h position (e.g. 100 bp upstream of the cap site in the ovalbumin promoter context) [22] .
In this connection it should be emphasized that the 3-4.5-fold enhancement of transcription obtained from GRE-TAT !.$& in the presence of rat liver CNEs and exogenous hGRα fits the above-mentioned results. In fact GRE-TAT !.$& is a chimaeric promoter\enhancer element that encompasses a single TAT-GREII (i.e. a single GRE\PRE 5h flanked by a CCAAT sequence) inserted in a remote position (350 bp upstream of the cap site) 5h to the liver-specific TAT !.$& promoter. Because the trans-acting factor that interacts with the CCAAT sequence located immediately 5h of the GRE\PRE inverted palindrome in TAT-GREII (a putative C\EBP cis-element) [9] acts synergistically with the GR in transient transfection, it might also be involved in the hGRα-dependent increase in transcription in itro. However, owing to the remote position of the TAT-GREII in GRE-TAT !.$& , one can speculate that the GRE\PRE-CCAAT synergism is attenuated in the transcription assay in itro and thus that hGRα yields a 3-4.5-fold rather than a 10-30-fold enhancement of transcription. Such a functional interaction (and even a synergism) between the steroid response and the binding of trans-acting factors to promoter elements has already been shown in itro for NF1 and an NF1-like trans-acting factor in the context of ovalbumin and vitellogenin B1 promoters respectively [22, 41] .
We have already shown that impaired GR transformation was the major step involved in the mechanism of RU486 antiglucocorticoid effect [42] . Thus we have previously documented that transformed RU486-GR complexes (i) are able to interact with GRE\PREs in itro and (ii) are as able as agonist-GR complexes to induce gene transcription when purified and added to chick oviduct nuclei [43] . Our results in transcription in itro are consistent with these previously reported results : RU486-hGRα complexes and TA-hGRα complexes are equally active in enhancing hGRα-mediated transcription in itro from GRE-TAT !.$& . Identical results were obtained by Tsai et al. [14] . These observations suggest that when hGRα is stripped of hsp90 and of other putative ' inhibitory ' protein(s) the conformations of agonist-aporeceptor and antagonist-aporeceptor complexes are closely related, so that the DNA-binding and trans-activating domain(s) are functional, at least in our transcription assay in itro. In this connection it has been hypothesized that not only hsp90 but also hsp70 has to be stripped from the 4 S progesterone receptor for transcription to be enhanced [18] . In the liver, TAT gene transcription is controlled by a variety of hormonal stimuli (glucocorticoids, glucagon and insulin) ; this control is often dependent on tissue-specific gene expression (e.g. the enhancement of TAT gene transcription by glucocorticoids and cAMP is dependent on liver-specific cis-elements, HNF3 and HNF4 respectively) (reviewed in [10] ). These hormonal stimuli are transduced by different pathways (nuclear receptors, adenyl cyclase-associated receptors and cAMP-dependent protein kinase, tyrosine kinase receptors) and in some instances are antagonistic (e.g. insulin inhibits the stimulation of TAT gene transcription induced by the glucocorticoids and by cAMP). These results suggest (i) that the cross-talk between various hormonal stimuli might converge towards either identical or at least closely overlapping-end molecular targets and (ii) that liverspecific trans-acting factors might also take part in this cross-talk (e.g. the inibitory effects of insulin on TAT gene transcription are dependent on both the cAMP response element and HNF3 cisacting sequence) [44] .
The experiments reported here clearly show that supplementation of liver CNEs with exogenous hGRα allows liver-specific, receptor-mediated enhancement of transcription in itro from a chimaeric reporter construct that encompasses a liver-specific promoter and a remote (350 bp upstream of the transcription initiation site) GRE\PRE. Such an assay will help study the functional role of liver-specific trans-acting factors and of their post-translational modifications (i) in the fine tuning of transcription in response to hormonal stimuli (glucocorticoid or cAMP) and (ii) in the cross-talk between signal transduction pathways at the molecular level.
